Press "Enter" to skip to content
The manufacturer suggests stocking up before the drug is taken off the market.

Controversial drug not harmful, says company that sells it

ISCHEMATOWN – The company that makes billions of dollars from the sale of a controversial drug contend that it is safe for customers to continue buying it.

The drug from Pferck Laboratories has been the target of a hail of class-action lawsuits, but is “no cause for concern,” said Nathan Therm, an attorney retained by the company to say so.

“There has been some statistical suggestion – suggestion – that Necropsifloxib is less safe than aspirin or placebo,” said Therm. “but there also evidence showing it is less fatal than cyanide tablets in a double-blind clinical trial.”

Necropsifloxib, in various phases under the brand names Rigortin, Mortox and Euthanesta, was marketed as a treatment for osteoarthritis, peptic ulcers, acne vulgaris and hangnail.

Be First to Comment

    Comments, Complaints, Recipes